After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Yahoo Finance discussed the stock recently as it posted Stelo by Dexcom First Glucose Biosensor to be Cleared by FDA as Over-the-Counter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Dexcom Inc is listed on the NASDAQ in the Healthcare sector while operating in the Medical Devices industry. At the end of the last regular session, the stock closed at $133.04 and fluctuated between $136.40 as its day high and $133.01 as its day low. The current market capitalization of Dexcom Inc is $51.29B. A total of 2.87 million shares were traded on the day, compared to an average of 3.12M shares.
In the most recent transaction, Sylvain Jereme M sold 3,363 shares of DXCM for 116.73 per share on Feb 20 ’24. After the transaction, the EVP Chief Financial Officer now owns 71,142 company shares. In a previous transaction on Jan 16 ’24, SAYER KEVIN R sold 37,325 shares at 123.63 per share. DXCM shares that President, CEO and Chairman owns now total 362,841.
Among the insiders who sold shares, Leach Jacob Steven disposed of 3,978 shares on Jan 16 ’24 at a per-share price of $123.63. This resulted in the EVP Chief Operating Officer holding 262,499 shares of DXCM after the transaction. In another insider transaction, Stern Sadie sold 2,902 shares at $123.63 per share on Jan 16 ’24. Company shares held by the EVP Chief Human Resources now total 79,051.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, DXCM has a high of $139.55 and a low of $74.75.
As of this writing, DXCM has an earnings estimate of $0.27 per share for the current quarter. EPS was calculated based on a consensus of 19 estimates, with a high estimate of $0.34 per share and a lower estimate of $0.21. The company reported an EPS of $0.5 in the last quarter, which was 47.10% higher than expectations of $0.34.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. DXCM’s latest balance sheet shows that the firm has $2.73B in Cash & Short Term Investments as of fiscal 2021. There were $2.16B in debt and $720.80M in liabilities at the time. Its Book Value Per Share was $5.37, while its Total Shareholder’s Equity was $2.04B.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DXCM is Buy with a score of 4.80.
